Clinical trials are complex undertakings and whether by necessity or strategic design, an increasing number of trials are now outsourced by pharma and biotech firms. This often requires the use of multiple partners to complete all aspects of a clinical trial. Greg Guarasci (Senior Vice President, Operations and General Partner) is joined by Lara Longpre of Jennerex Biotherapeutics to consider if these multiple partnerships are the way of the future,
Explore related content and topics
Webinar
The Challenges of Patient Recruitment in Oncology Trials - Part 2
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia…
Publication
The True Cost of Ineffective Clinical Trials
The process of designing and implementing clinical trials hasn’t changed much over the decades — which may be why 1 in 5 clinical trials fail due to…
Fact Sheet
Center for Pediatric Clinical Development Fact Sheet
The NIH reports that 70% of medicines given to children have only been studied in adults; therefore, most drugs used to treat diseases in children…